Separation of 16 Cannabinoids in Cannabis Flower and Extracts Using a Reversed-Phase Isocratic HPLC Method

Importance of the Topic

As cannabis legalization advances for medicinal and recreational use, reliable analytical methods for potency determination and cannabinoid profiling are essential. The complexity of Cannabis sativa—with over 100 known cannabinoids—demands robust separations to distinguish major and minor components accurately for quality control, regulatory compliance, and consumer safety.

Objectives and Study Overview

This application note presents the development and validation of a simple reversed-phase isocratic HPLC method to separate and quantify 16 cannabinoids in cannabis flower and extract samples. The method is evaluated for chromatographic resolution, linearity, and applicability across diverse sample matrices.

Methodology

An Alliance HPLC system was operated isocratically with a mobile phase of 41:59 water (0.1% TFA) to acetonitrile at 2.0 mL/min and 35 °C using a CORTECS Shield RP18 column (2.7 µm, 4.6 × 150 mm). Detection employed a 2998 PDA detector at 228 nm with a 5 µL injection. Calibration for d9-THC, THC-A, CBD, CBD-A, and CBN covered 0.004–1.000 mg/mL. Flower and concentrate samples were extracted with acetonitrile, ethanol, or isopropanol, filtered, diluted in methanol, and analyzed under identical conditions.

Used Instrumentation

• Waters Alliance HPLC System
• Waters 2998 Photodiode Array Detector
• Empower 3 Chromatography Data Software
• CORTECS Shield RP18 Column (p/n 186008685)

Results and Discussion

The method achieved baseline separation of all 16 cannabinoids within 26 minutes, with resolution factors exceeding 2.5. Linearity for the five major analytes demonstrated R² > 0.999 across ten concentration levels. Representative chromatograms from high-CBD-A and high-THC-A flower, concentrates, and hemp flower samples confirmed accurate quantitation (reported as % dry weight) and detection of minor cannabinoids without co-elution.

Benefits and Practical Applications

• Isocratic operation and automated solvent blending reduce manual preparation errors and variability.
• Single-wavelength PDA detection simplifies routine analysis while retaining full-scan data for purity checks or library matching.
• Comprehensive separation of major and minor cannabinoids supports potency reporting, product development, and regulatory compliance.

Future Trends and Opportunities

Industry standardization efforts will drive harmonized cannabinoid profiling protocols to improve interlaboratory consistency. Further advances may include UHPLC and mass spectrometry coupling for enhanced sensitivity, novel stationary phases for faster separations, automation workflows for high throughput, and deeper exploration of emerging minor cannabinoids and terpene interactions for therapeutic applications.

Conclusion

The described isocratic HPLC method using a CORTECS Shield RP18 column offers a rapid, reliable, and easy-to-implement solution for the routine analysis of 16 cannabinoids in diverse cannabis matrices, meeting the needs of producers, regulators, and laboratories.

Reference

1. Radwan MM, Wanas AS, Chandra S, ElSohly MA. Natural Cannabinoids of Cannabis and Methods of Analysis. In: Cannabis sativa L. Botany and Biotechnology. Springer; 2017.
2. Layton CE, Aubin AJ. Method Validation for Assay Determination of Cannabidiol Isolates. J Liq Chromatogr Rel Technol. 2018;41(3).
3. Layton CE, Aubin AJ. Considerations When Handling DEA-Exempt Cannabinoid Reference Standard Preparations. Presented at the 4th Annual Emerald Conference; 2018.
4. Upton R, ed. Cannabis inflorescence: Standards of Identity, Analysis, and Quality Control. American Herbal Pharmacopoeia; 2014.
5. Patel B, Wene D, Fan ZT. Measurement of Cannabinoids in Cannabis using HPLC/DAD. J Pharm Biomed Anal. 2017;146:15–23.
6. Giese M, et al. Development and Validation of a Method for Cannabinoids and Terpenes in Cannabis. J AOAC Int. 2015;98(6).
7. Swartz ME, Krull IS. Handbook of Analytical Validation. CRC Press; 2012.
8. Waters. Automated Solvent Blending Enhances HPLC Performance. Performance PerSPECtives no:720000294EN; 2003.
9. Waters. Peak Purity I: What is Peak Purity Analysis? Performance PerSPECtives no:wpp16; 1996.